Bausch Health Cos ROA 2012-2026 | BHC
Current and historical return on assets (ROA) values for Bausch Health Cos (BHC) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
| Bausch Health Cos ROA - Return on Assets Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Total Assets | Return on Assets |
| 2026-03-31 | $-1.21B | $26.24B | -4.60% |
| 2025-12-31 | $0.16B | $26.72B | 0.59% |
| 2025-09-30 | $0.36B | $26.76B | 1.35% |
| 2025-06-30 | $0.10B | $26.69B | 0.37% |
| 2025-03-31 | $-0.04B | $26.50B | -0.15% |
| 2024-12-31 | $-0.05B | $26.62B | -0.17% |
| 2024-09-30 | $-0.18B | $26.83B | -0.66% |
| 2024-06-30 | $-0.47B | $26.96B | -1.75% |
| 2024-03-31 | $-0.46B | $26.71B | -1.70% |
| 2023-12-31 | $-0.59B | $26.34B | -2.25% |
| 2023-09-30 | $-0.96B | $25.93B | -3.71% |
| 2023-06-30 | $-0.19B | $25.73B | -0.72% |
| 2023-03-31 | $-0.36B | $26.40B | -1.35% |
| 2022-12-31 | $-0.23B | $27.31B | -0.82% |
| 2022-09-30 | $0.25B | $28.19B | 0.90% |
| 2022-06-30 | $0.04B | $28.93B | 0.15% |
| 2022-03-31 | $-0.41B | $29.40B | -1.38% |
| 2021-12-31 | $-0.95B | $29.67B | -3.19% |
| 2021-09-30 | $-1.17B | $30.17B | -3.88% |
| 2021-06-30 | $-1.29B | $30.75B | -4.19% |
| 2021-03-31 | $-1.02B | $31.09B | -3.27% |
| 2020-12-31 | $-0.56B | $31.51B | -1.78% |
| 2020-09-30 | $-1.92B | $32.17B | -5.98% |
| 2020-06-30 | $-2.04B | $32.20B | -6.35% |
| 2020-03-31 | $-1.89B | $32.44B | -5.82% |
| 2019-12-31 | $-1.79B | $32.61B | -5.48% |
| 2019-09-30 | $-0.62B | $32.27B | -1.91% |
| 2019-06-30 | $-0.92B | $32.79B | -2.80% |
| 2019-03-31 | $-1.62B | $33.32B | -4.86% |
| 2018-12-31 | $-4.15B | $34.13B | -12.15% |
| 2018-09-30 | $-3.29B | $35.38B | -9.30% |
| 2018-06-30 | $-1.64B | $36.93B | -4.44% |
| 2018-03-31 | $-0.81B | $38.75B | -2.08% |
| 2017-12-31 | $2.40B | $40.38B | 5.95% |
| 2017-09-30 | $1.38B | $41.89B | 3.28% |
| 2017-06-30 | $-1.14B | $43.34B | -2.64% |
| 2017-03-31 | $-1.41B | $44.82B | -3.14% |
| 2016-12-31 | $-2.41B | $46.49B | -5.18% |
| 2016-09-30 | $-2.28B | $47.85B | -4.76% |
| 2016-06-30 | $-1.01B | $48.53B | -2.09% |
| 2016-03-31 | $-0.76B | $48.70B | -1.57% |
| 2015-12-31 | $-0.29B | $46.08B | -0.63% |
| 2015-09-30 | $0.60B | $40.42B | 1.48% |
| 2015-06-30 | $0.82B | $35.07B | 2.34% |
| 2015-03-31 | $1.00B | $29.96B | 3.34% |
| 2014-12-31 | $0.88B | $27.31B | 3.22% |
| 2014-09-30 | $0.50B | $27.73B | 1.81% |
| 2014-06-30 | $-0.75B | $28.02B | -2.66% |
| 2014-03-31 | $-0.86B | $25.99B | -3.31% |
| 2013-12-31 | $-0.87B | $23.36B | -3.71% |
| 2013-09-30 | $-1.08B | $20.86B | -5.17% |
| 2013-06-30 | $-0.10B | $17.34B | -0.57% |
| 2013-03-31 | $-0.13B | $15.90B | -0.82% |
| 2012-12-31 | $-0.12B | $14.93B | -0.78% |
| 2012-09-30 | $0.03B | $13.72B | 0.21% |
| 2012-06-30 | $0.06B | $13.14B | 0.47% |
| 2012-03-31 | $0.14B | $12.59B | 1.11% |
| 2011-12-31 | $0.16B | $12.11B | 1.31% |
| 2011-09-30 | $0.07B | $11.53B | 0.62% |
| 2011-06-30 | $-0.18B | $11.36B | -1.56% |
| 2011-03-31 | $-0.20B | $8.91B | -2.23% |
| 2010-12-31 | $-0.21B | $6.49B | -3.20% |
| 2010-09-30 | $-0.10B | $4.31B | -2.41% |
| 2010-06-30 | $0.14B | $2.03B | 7.10% |
| 2010-03-31 | $0.13B | $2.04B | 6.58% |
| 2009-12-31 | $0.18B | $1.92B | 9.15% |
| 2009-09-30 | $0.22B | $1.82B | 12.28% |
| 2009-06-30 | $0.23B | $1.69B | 13.71% |
| 2009-03-31 | $0.18B | $1.58B | 11.52% |
| 2008-12-31 | $0.20B | $1.64B | 12.14% |
| 2008-09-30 | $0.05B | $1.68B | 2.80% |
| 2008-06-30 | $0.07B | $1.73B | 3.76% |
| 2008-03-31 | $0.16B | $1.76B | 8.97% |
| 2007-12-31 | $0.20B | $1.86B | 10.53% |
| 2007-09-30 | $0.34B | $1.96B | 17.50% |
| 2007-06-30 | $0.22B | $2.05B | 10.78% |
| 2007-03-31 | $0.23B | $2.14B | 10.94% |
| 2006-12-31 | $0.20B | $2.11B | 9.69% |
| 2006-09-30 | $0.21B | $2.07B | 10.10% |
| 2006-06-30 | $0.37B | $2.03B | 18.09% |
| 2006-03-31 | $0.29B | $2.02B | 14.36% |
| 2005-12-31 | $0.24B | $1.93B | 12.28% |
| 2005-09-30 | $0.16B | $1.85B | 8.81% |
| 2005-06-30 | $0.11B | $1.82B | 6.11% |
| 2005-03-31 | $0.15B | $1.74B | 8.68% |
| 2004-12-31 | $0.16B | $1.77B | 9.10% |
| 2004-09-30 | $0.02B | $1.82B | 1.04% |
| 2004-06-30 | $-0.02B | $1.89B | -0.95% |
| 2004-03-31 | $-0.06B | $1.95B | -3.22% |
| 2003-12-31 | $-0.02B | $1.94B | -1.08% |
| 2003-09-30 | $-0.03B | $1.92B | -1.46% |
| 2003-06-30 | $0.03B | $1.82B | 1.86% |
| 2003-03-31 | $0.10B | $1.70B | 5.76% |
| 2002-12-31 | $0.09B | $1.64B | 5.35% |
| 2002-09-30 | $0.17B | $1.52B | 11.33% |
| 2002-06-30 | $0.13B | $1.36B | 9.54% |
| 2002-03-31 | $0.11B | $1.32B | 8.40% |
| 2001-12-31 | $0.09B | $1.19B | 7.30% |
| 2001-09-30 | $0.08B | $1.23B | 6.78% |
| 2001-06-30 | $-0.05B | $1.13B | -4.69% |
| 2001-03-31 | $-0.08B | $0.97B | -7.70% |
| 2000-12-31 | $-0.11B | $0.90B | -12.33% |
| 2000-09-30 | $-0.06B | $0.69B | -9.08% |
| 2000-06-30 | $0.06B | $0.59B | 9.69% |
| 2000-03-31 | $0.05B | $0.45B | 10.40% |
| 1999-12-31 | $0.06B | $0.32B | 19.38% |
| 1999-09-30 | $0.05B | $0.21B | 24.62% |
| 1999-06-30 | $0.05B | $0.19B | 25.88% |
| 1999-03-31 | $0.05B | $0.17B | 27.92% |
| 1998-12-31 | $0.05B | $0.15B | 31.67% |
| 1998-09-30 | $0.04B | $0.10B | 46.19% |
| 1998-06-30 | $0.04B | $0.06B | 63.75% |
| 1998-03-31 | $0.04B | $0.05B | 73.63% |
| 1997-12-31 | $0.04B | $0.04B | 99.29% |
| 1997-09-30 | $0.03B | $0.05B | 58.00% |
| 1997-06-30 | $0.03B | $0.07B | 38.95% |
| 1997-03-31 | $0.03B | $0.07B | 38.76% |
| 1996-12-31 | $0.02B | $0.05B | 48.48% |
| 1996-09-30 | $0.02B | $0.05B | 40.00% |
| 1996-06-30 | $0.02B | $0.03B | 45.11% |
| 1996-03-31 | $0.01B | $0.02B | 54.55% |
| 1995-12-31 | $0.01B | $0.02B | 32.79% |
| 1995-09-30 | $0.00B | $0.01B | 61.54% |
| 1995-06-30 | $0.00B | $0.01B | 46.15% |
| 1995-03-31 | $0.00B | $0.02B | 13.79% |
| 1994-12-31 | $0.01B | $0.02B | 62.07% |
| 1994-06-30 | $0.01B | $0.02B | 44.44% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Generic Drugs | $2.086B | $10.266B |
| Bausch Health Companies Inc. develops, manufactures and markets a wide array of branded, generic and branded generic pharmaceuticals, over-the-counter (OTC) products along with medical devices such as contact lenses, intraocular lenses, ophthalmic surgical equipment, and aesthetics devices in the therapeutic areas of eye-health, gastroenterology (GI), and dermatology. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Teva Pharmaceutical Industries (TEVA) | Israel | $35.437B | 10.97 |
| BridgeBio Pharma (BBIO) | United States | $14.460B | 0.00 |
| Dr Reddy's Laboratories (RDY) | India | $11.109B | 17.29 |
| Aspen Pharmacare (APNHY) | South Africa | $3.708B | 0.00 |
| Supernus Pharmaceuticals (SUPN) | United States | $2.918B | 22.33 |
| Taysha Gene Therapies (TSHA) | United States | $1.290B | 0.00 |
| Amphastar Pharmaceuticals (AMPH) | United States | $0.924B | 7.28 |
| Personalis (PSNL) | United States | $0.630B | 0.00 |
| Assembly Biosciences (ASMB) | United States | $0.451B | 0.00 |
| Sol-Gel Technologies (SLGL) | Israel | $0.210B | 0.00 |
| Metagenomi Therapeutics (MGX) | United States | $0.052B | 0.00 |
| Evoke Pharma (EVOK) | United States | $0.019B | 0.00 |
| Teligent (TLGT) | United States | $0.000B | 0.00 |